NDAINTRAVENOUSSOLUTION
Approved
Mar 2014
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Loss of Exclusivity
LOE Date
Jul 14, 2032
77 months away
Patent Expiry
Jul 14, 2032